Phase II study to evaluate the efficacy of intra-bone cord blood transplantation for adult patients with hematological malignancy
Phase 2
- Conditions
- Hematological malignancy
- Registration Number
- JPRN-UMIN000020997
- Lead Sponsor
- Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1. Positive for HBs-Ag, HCV-Ab, or HIV-Ab 2. In pregnancy or breast-feeding 3. Double cancer 4. Uncontrolled psychiatric disorder 5. Uncontrolled infectious disease 6. Allergy to drugs for transplant preconditioning or GVHD prophylaxis 7. Re-transplantation within 6 months from the preceding transplantation 8. Doctor's decision
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival rate with neutrophil engraftment on day 28 after transplantation
- Secondary Outcome Measures
Name Time Method